Hikma Pharmaceuticals PLC (HIK) — Long-term Investment Intensity
Hikma Pharmaceuticals PLC (HIK) has a Long-term Investment Intensity of 1.1% as of December 2019. Long-term investments of GBX43.00 Million represent 1.1% of total assets of GBX3.93 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Hikma Pharmaceuticals PLC (HIK) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Hikma Pharmaceuticals PLC Long-term Investment Intensity (2013–2019)
This chart shows how Hikma Pharmaceuticals PLC's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 1.1%, reflecting long-term investments of GBX43.00 Million against total assets of GBX3.93 Billion GBX. For the complete balance sheet picture, see HIK total assets.
Annual Long-term Investment Intensity for Hikma Pharmaceuticals PLC (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Hikma Pharmaceuticals PLC from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read HIK total debt and obligations for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (GBX) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.1% | GBX43.00 Million | GBX3.93 Billion | ▲ +0.0 pp |
| 2018 | 1.1% | GBX38.00 Million | GBX3.50 Billion | ▲ +0.4 pp |
| 2017 | 0.6% | GBX22.00 Million | GBX3.39 Billion | ▲ +0.3 pp |
| 2016 | 0.3% | GBX14.00 Million | GBX4.36 Billion | ▼ 0.0 pp |
| 2015 | 0.3% | GBX9.00 Million | GBX2.60 Billion | ▼ -0.5 pp |
| 2014 | 0.8% | GBX18.00 Million | GBX2.25 Billion | ▼ -0.4 pp |
| 2013 | 1.2% | GBX24.00 Million | GBX1.93 Billion | — |